Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.130
-0.020 (-1.74%)
At close: Feb 27, 2026, 4:00 PM EST
1.160
+0.030 (2.65%)
After-hours: Feb 27, 2026, 7:51 PM EST
Clearmind Medicine Income Statement
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
| Selling, General & Admin | 3.61 | 4.36 | 4.76 | 3.17 | 2.44 | |
| Research & Development | 2.06 | 1.38 | 1.54 | 3.08 | 0.52 | |
| Operating Expenses | 5.67 | 5.74 | 6.3 | 6.25 | 2.97 | |
| Operating Income | -5.67 | -5.74 | -6.3 | -6.25 | -2.97 | |
| Interest Expense | -0.02 | -0.04 | -0.01 | -0.01 | - | |
| Interest & Investment Income | 0.13 | 0.27 | 0.09 | - | - | |
| Currency Exchange Gain (Loss) | 0 | -0.01 | -0.08 | -0 | -0.03 | |
| Other Non Operating Income (Expenses) | 1.13 | 0.71 | -2.19 | -0.29 | - | |
| EBT Excluding Unusual Items | -4.42 | -4.81 | -8.5 | -6.56 | -3 | |
| Gain (Loss) on Sale of Investments | 0.84 | -0.07 | -0.11 | -0.31 | - | |
| Other Unusual Items | -0.21 | - | - | - | - | |
| Pretax Income | -3.79 | -4.88 | -8.6 | -6.87 | -3 | |
| Income Tax Expense | 0.07 | 0.38 | 0.02 | 0.03 | - | |
| Net Income | -3.86 | -5.25 | -8.62 | -6.89 | -3 | |
| Net Income to Common | -3.86 | -5.25 | -8.62 | -6.89 | -3 | |
| Shares Outstanding (Basic) | 0 | 0 | - | - | - | |
| Shares Outstanding (Diluted) | 0 | 0 | - | - | - | |
| Shares Change (YoY) | 63.98% | - | - | - | - | |
| EPS (Basic) | -30.35 | -67.80 | - | - | - | |
| EPS (Diluted) | -30.35 | -67.80 | - | - | - | |
| Free Cash Flow | -4.73 | -4.86 | -6.3 | -3.73 | -2.31 | |
| Free Cash Flow Per Share | -37.25 | -62.69 | - | - | - | |
| EBITDA | -5.66 | -5.73 | -6.28 | -6.23 | -2.96 | |
| D&A For EBITDA | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | |
| EBIT | -5.67 | -5.74 | -6.3 | -6.25 | -2.97 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.